PhD position in Molecular Immunology (Biotechnology)
- Last application date: Jun 30, 2015 23:40
- Department: WE14 – Department of Biomedical molecular biology
- Contract: Limited duration
- Degree: Master degree in Biotechnology, Biochemistry, Medicine, Bio-engineering, Pharmacy or similar life sciences
- Occupancy rate: 100%
- Vacancy Type: Research staff
Job description
The PhD research will focus on the study of molecular mechanisms of TLR4 induced immune responses and the characterization of the therapeutic effect of TLR4 modulators in cellular models and mouse models of human disease. The candidate will follow training programs organized by different partners of the TOLLerant network, which will provide PhD students with broad competences, experience and skills in cutting-edge interdisciplinary research related to molecular mechanisms of innate immunity. The project involves a series of secondments at academic partner labs in Italy, Spain, Germany and/or Slovenia, and in the labs of industrial partners in Spain and Italy. These industry partner labs will provide PhD students with entrepreneurship and company management skills, in order to enhance their later possible employment in the private sector.
Qualifications
- Have a diploma and/or Master Degree in Biotechnology, Biochemistry, Medicine, Bio-engineering, Pharmacy or similar life sciences.
- Have less than 4 years research experience (measured from the time the Master degree has been obtained) at the signature of the contract.
- Not have a PhD already.
- Not have resided or carried out main activity (work, studies, etc.) in Belgium for more than 12 months in the 3 years immediately prior to the reference recruitment date.
- Excellent knowledge of English language, spoken and written.
- Practical experience in molecular/cellular immunology and working with mice is an advantage.
How to apply
Candidates should send a CV, motivation letter, and the names and contact details of at least 3 references by e-mail to Rudi Beyaert (rudi@irc.vib-ugent.be) indicating TOLLerant in the subject.
Deadline: Jun 30, 2015